Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.

Jihane BelayachiMajdouline ObtelAbdelkader MhayiRachid Razine Redouane Abouqal

Published in: PloS one (2022)

A Sinopharm vaccine is highly protective against serious SARS-CoV-2 infection under real-world conditions. Protection remained high and stable during the first three months following the second dose and decreases slightly beyond the fourth month especially beyond 60 years.

Keyphrases

induced apoptosis
coronavirus disease
sars cov
cell cycle arrest
randomized controlled trial
respiratory syndrome coronavirus
early onset
endoplasmic reticulum stress
cell death
cell proliferation
drug induced